SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-088699
Filing Date
2022-08-10
Accepted
2022-08-10 17:25:40
Documents
20
Period of Report
2022-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2222304d3_8k.htm   iXBRL 8-K 33891
2 EXHIBIT 1.1 tm2222304d3_ex1-1.htm EX-1.1 225724
3 EXHIBIT 4.1 tm2222304d3_ex4-1.htm EX-4.1 100268
4 EXHIBIT 4.2 tm2222304d3_ex4-2.htm EX-4.2 140625
5 EXHIBIT 5.1 tm2222304d3_ex5-1.htm EX-5.1 15711
6 EXHIBIT 99.1 tm2222304d3_ex99-1.htm EX-99.1 10496
7 EXHIBIT 99.2 tm2222304d3_ex99-2.htm EX-99.2 11474
11 GRAPHIC tm2222304d3_ex99-2img001.jpg GRAPHIC 3012
12 GRAPHIC tm2222304d3_ex99-1img001.jpg GRAPHIC 3043
  Complete submission text file 0001104659-22-088699.txt   845934

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA aytu-20220808.xsd EX-101.SCH 3030
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aytu-20220808_lab.xml EX-101.LAB 34476
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aytu-20220808_pre.xml EX-101.PRE 22593
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2222304d3_8k_htm.xml XML 3611
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 221152846
SIC: 2834 Pharmaceutical Preparations